These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 23107257)
1. Visceral fat and metabolic inflammation: the portal theory revisited. Item F; Konrad D Obes Rev; 2012 Dec; 13 Suppl 2():30-9. PubMed ID: 23107257 [TBL] [Abstract][Full Text] [Related]
2. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution. Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466 [TBL] [Abstract][Full Text] [Related]
3. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC; Berk PD Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [TBL] [Abstract][Full Text] [Related]
4. [NASH in children]. Ida S; Yoshimura N Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127 [TBL] [Abstract][Full Text] [Related]
5. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994 [TBL] [Abstract][Full Text] [Related]
6. Is visceral fat reduction necessary to favour metabolic changes in the liver? Finelli C; Tarantino G J Gastrointestin Liver Dis; 2012 Jun; 21(2):205-8. PubMed ID: 22720311 [TBL] [Abstract][Full Text] [Related]
7. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. van der Heijden GJ; Wang ZJ; Chu ZD; Sauer PJ; Haymond MW; Rodriguez LM; Sunehag AL Obesity (Silver Spring); 2010 Feb; 18(2):384-90. PubMed ID: 19696755 [TBL] [Abstract][Full Text] [Related]
8. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice. Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225 [TBL] [Abstract][Full Text] [Related]
9. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Lafontan M; Girard J Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411 [TBL] [Abstract][Full Text] [Related]
11. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758 [TBL] [Abstract][Full Text] [Related]
14. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. Fishbein MH; Mogren C; Gleason T; Stevens WR J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259 [TBL] [Abstract][Full Text] [Related]
15. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Black PH Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084 [TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Francque S; Verrijken A; Mertens I; Hubens G; Van Marck E; Pelckmans P; Michielsen P; Van Gaal L Int J Obes (Lond); 2011 Feb; 35(2):270-8. PubMed ID: 20661251 [TBL] [Abstract][Full Text] [Related]
17. Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. Targher G; Zoppini G; Moghetti P; Day CP Semin Thromb Hemost; 2010 Feb; 36(1):41-8. PubMed ID: 20391295 [TBL] [Abstract][Full Text] [Related]
18. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841 [TBL] [Abstract][Full Text] [Related]
19. [Metabolic difference between visceral fat and subcutaneous abdominal fat]. Björntorp P Diabetes Metab; 2000 Jun; 26 Suppl 3():10-2. PubMed ID: 10945144 [TBL] [Abstract][Full Text] [Related]